In recent years, we have successfully developed advanced technologies to extract active peptides directly from organelles of specific organs. This breakthrough enables precise application in regenerative medicine to enhance cell function, achieve targeted therapy and optimize treatment options.
By harnessing the power of organ-specific peptides, we are paving the way for the next generation of health innovation, providing personalized solutions to support recovery, longevity and overall health.
Extending the quality of life. Several therapeutic technologies have been proposed. We have developed novel peptide therapies for both clinical and organ-specific stem cell derived peptides under the name Ryvaltech. Our stem cell organelle peptide therapy, is comprised of signaling peptides that are associated with the maintenance of regular bone, cartilage, joint and synovial guidsand are found in the placenta, central nervous system, and thymus. Blood analysis was conducted to assess whole blood count and chemistry. Our results indicated that Stem cell organelle peptides injection did not cause observable side effects.
